A Mirror-Image L-RNA Aptamer Targeting Hypoxia-Inducible Factor-1α Promoter G-Quadruplex Potentiates Tumor Radiotherapy In Vivo
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Thus, L-Apt5–4 represents a novel HIF-1α-targeted therapeutic and radiosensitizer for combined cancer treatment.
Appeared: Wednesday, November 18. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c18490